New trends for the development of novel decoy molecules against nuclear factor kappa-B (NF-kB) transcription factor

Minerva Biotecnologica

Volumn 16, Issue 2, 2004, Pages 145-149

  Gambari, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Inflammation; NF kappa B; Nucleic acids; Transcription factors

Indexed keywords

ANTIINFLAMMATORY AGENT; COMPLEMENTARY DNA; COMPLEMENTARY RNA; DNA; DNA HYBRID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOSOME; MICROSPHERE; NUCLEASE; PEPTIDE NUCLEIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; WATER;

BINDING SITE; CELL NUCLEUS; CELLULAR DISTRIBUTION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DELIVERY SYSTEM; GENE ACTIVATION; GENETIC ENGINEERING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INFLAMMATION; INTERNALIZATION; LONG TERMINAL REPEAT; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; SOLUBILITY; TARGET CELL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 4844228985     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Wright JG, Christman JW. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir Med 2003;2:211-9.
2. Takada Y, Singh S, Aggarwal BB. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in downregulation of NF-kappa B-mediated gene expression and upregulation of apoptosis. J Biol Chem 2004 Jan 7 [Epub ahead of print].
3. Schmidt C, Peng B, Li Z, Sclabas GM, Fujioka S, Niu J et al. Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation. Mol Cell 2003;12:1287-300.
4. Liden J, Ek A, Palmberg L, Okret S, Larsson K. Organic dust activates NF-kappaB in lung epithelial cells. Respir Med 2003;97:882-92.
5. Bacot SM, Lenz P, Frazier-Jessen MR, Feldman GM. Activation by prion peptide PrP106-126 induces a NF-kappaB-driven proinflammatory response in human monocyte-derived dendritic cells. J Leukoc Biol 2003;74:118-25.
6. Niessner A, Kaun C, Zorn G, Speidl W, Turel Z, Christiansen G et al. Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway. J Infect Dis 2003; 188:108-13.
7. Shi XZ, Lindholm PF, Sarna SK. NF-kappa B activation by oxidative stress and inflammation suppresses contractility in colonic circular smooth muscle cells. Gastroenterology 2003;124:1369-80.
8. Yamaza T, Masuda KF, Tsukiyama Y, Nishijima K, Murakarmi R, Kido MA et al. NF-kappaB activation and iNOS expression in the synovial membrane of rat temporomandibular joints after induced synovitis. J Dent Res 2003;82:183-8.
9. Yamasaki K, Asai T, Shimizu M, Aoki M, Hashiya N, Sakonjo H et al. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Gene Ther 2003;10:356-64.
10. Hassa PO, Hottiger MO. The functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol Life Sci 2002;59:1534-53.
11. Mann MJ, Dzau VJ. Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest 2000;106:1071-5.
12. Cho-Chung YS, Park YG, Nesterova M, Lee YN, Cho YS. CRE-decoy oligonucleotide-inhibition of gene expression and tumor growth. Mol Cell Biochem 2000;212:29-34.
13. Piva R, Gambari R. Transcription factor decoy (TFD) in breast cancer research and treatment. Technol Cancer Res Treat 2002;1:405-16.
14. Nielsen PE, Egholm M, Berg RH, Buchardt O. Sequence selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 1991;254:1497-500.
15. Egholm M, Buchardt O, Nielsen PE, Berg RH. Peptide nucleic acids (PNA). Oligonucleotide analogues with an achiral peptide backbone. J Am Chem Soc 1992; 114:1895-7.
16. Good L, Nielsen PE. Progress in developing PNA as gene targeted drugs. Antisense Nucleic Acid Drug Dev 1997;7:431-7.
17. Nielsen PE. Peptide nucleic acids as therapeutic agents. Curr Opin Struct Biol 1999;9:353-7.
18. Braasch DA, Corey DR. Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry 2002;41: 4503-10.
19. Nielsen PE. Peptide nucleic acids (PNA): potential antiviral agents. Antiviral News 1993;1:37-9.
20. Gambari R. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers. Curr Pharm Des 2001;7:1839-62.
21. Mischiati C, Borgatti M, Bianchi N, Rutigliano C, Tomassetti M, Feriotto G et al. Interaction of the human NF-kappaB p52 transcription factor with DNA-PNA hybrids mimicking the NF-kappaB binding sites of the human immunodeficiency virus type 1 promoter. J Biol Chem 1999;274:33114-22.
22. Borgatti M, Lampronti I, Romanelli A, Pedone C, Saviano M, Bianchi N et al. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem 2003;278:7500-9.
23. van der Laan AC, Havenaar P, Oosting RS, Kuyl-Yeheskiely E, Uhlmann E, van Boom JH. Optimization of the binding properties of PNA-(5′)-DNA chimerae. Bioorg Med Chem Lett 1998;8:663-8.
24. Uhlmann E. Peptide nucleic acids (PNA) and PNA-DNA chimeras: from high binding affinity towards biological function. Biol Chem 1998;379:1045-52.
25. Misra HS, Pandey PK, Modak MJ, Vinayak R, Pandey VN. Polyamide nucleic acid-DNA chimera lacking the phosphate backbone are novel primers for polymerase reaction catalyzed by DNA polymerases. Biochemistry 1998;37:1917-25.
26. Koppitz M, Nielsen PE, Orgel LE. Formation of oligonucleotide PNA-chimeras by template-directed ligation. J Am Chem Soc 1998;120:4563-9.
27. Borgatti M, Breda L, Conesi R, Nastruzzi C, Romanelli A, Saviano M et al. Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors. Biochem Pharmacol 2002;64:609-16.
28. Romanelli A, Pedone C, Saviano M, Bianchi N, Borgatti M, Mischiati C et al. Molecular interactions with nuclear factor kappaB (NF-kappaB) transcription factors of a PNA-DNA chimera mimicking NF-kappaB binding sites. Eur J Biochem 2001;268:6066-75.
29. Saviano M, Romanelli A, Bucci E, Pedone C, Mischiati C, Bianchi N et al. Computational procedures to explain the different biological activity of DNA/DNA, DNA/PNA and PNA/PNA hybrid molecules mimicking NF-kappaB binding sites. J Biomol Struct Dyn 2000;18:353-62.
30. Penolazzi L, Borgatti M, Lambertini E, Mischiati M, Finotti A, Romanelli A et al. Peptide nucleic acids-DNA decoy chimeras targeting NF-kB transcription factors: induction of apoptosis in human primary osteoclasts. Int J Mol Med, submitted.
31. Borgatti M, Romanelli A, Saviano M, Pedone C, Lampronti I, Breda L et al. Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum. Oncol Res 2003;13:279-87.
32. Cortesi R, Mischiati C, Borgatti M, Breda L, Romanelli A, Saviano M et al. Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles. AAPS PharmSci 2002;6: article 2.
33. Mischiati C, Borgatti M, Breda L, Cortesi R, Nastruzzi C, Romanelli A et al. Complexation to cationic microspheres of double-stranded peptide nucleic acid (PNA)-DNA chimeras exhibiting decoy activity. J Biomed Sci, submitted.
34. Awasthi SK, Nielsen PE. Synthesis of PNA-peptide conjugates. Methods Mol Biol 2002;208:43-52.
35. Nielsen PE. PNA technology. Methods Mol Biol 2002;208:3-26.
36. Kaihatsu K, Braasch DA, Cansizoglu A, Corey DR. Enhanced strand invasion by peptide nucleic acid-peptide conjugates. Biochemistry 2002;41:11118-25.
37. Kumagai I, Takahashi T, Hamasaki K, Ueno A, Mihara H. HIV Rev peptides conjugated with peptide nucleic acids and their efficient binding to RRE RNA. Bioorg Med Chem Lett 2001;11: 1169-72.
38. Koppelhus U, Nielsen PE. Cellular delivery of peptide nucleic acid (PNA). Adv Drug Deliv Rev 2003;55:267-80.
39. Koppelhus U, Awasthi SK, Zachar V, Holst HU, Ebbesen P, Nielsen PE. Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Dev 2002;12:51-63.
40. Pope RM. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2002;2:527-35.
41. Knrre A, Wagner M, Schaefer HE, Colledge WH, Pahl HL. DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs. Biol Chem 2002;383:271-82.